SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kara M. Smith, Nabila Dahodwala, Sex differences in Parkinson's disease and other movement disorders, Experimental Neurology, 2014,

    CrossRef

  2. 2
    Mlanie Bourque, Marc Morissette, Mlissa Ct, Denis Soulet, Thrse Di Paolo, Implication of GPER1 in neuroprotection in a mouse model of Parkinson's disease, Neurobiology of Aging, 2013, 34, 3, 887

    CrossRef

  3. 3
    S. Al-Sweidi, M. Morissette, T. Di Paolo, Effect of Oestrogen Receptors on Brain NMDA Receptors of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mice, Journal of Neuroendocrinology, 2012, 24, 11
  4. 4
    Rebecca L. Cunningham, Teresa Macheda, Lora Talley Watts, Ethan Poteet, Meharvan Singh, James L. Roberts, Andrea Giuffrida, Androgens exacerbate motor asymmetry in male rats with unilateral 6-hydroxydopamine lesion, Hormones and Behavior, 2011, 60, 5, 617

    CrossRef

  5. 5
    Sara Al-Sweidi, Marc Morissette, Mélanie Bourque, Thérèse Di Paolo, Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson’s disease, Neuropharmacology, 2011, 61, 4, 583

    CrossRef

  6. 6
    Eleni Antzoulatos, Michael W. Jakowec, Giselle M. Petzinger, Ruth I. Wood, MPTP Neurotoxicity and Testosterone Induce Dendritic Remodeling of Striatal Medium Spiny Neurons in the C57Bl/6 Mouse, Parkinson's Disease, 2011, 2011, 1

    CrossRef

  7. 7
    M. L. Johnson, A. E. Day, C. C. Ho, Q. D. Walker, R. Francis, C. M. Kuhn, Androgen Decreases Dopamine Neurone Survival in Rat Midbrain, Journal of Neuroendocrinology, 2010, 22, 4
  8. 8
    Glenda E. Gillies, Simon McArthur, Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: A contribution to sex-specific neuroprotection by estrogens, Hormones and Behavior, 2010, 57, 1, 23

    CrossRef

  9. You have free access to this content9
    Maria Gabriela Sánchez, Mélanie Bourque, Marc Morissette, Thérèse Di Paolo, Steroids-Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders, CNS Neuroscience & Therapeutics, 2010, 16, 3
  10. 10
    Mélanie Bourque, Dean E. Dluzen, Thérèse Di Paolo, Neuroprotective actions of sex steroids in Parkinson’s disease, Frontiers in Neuroendocrinology, 2009, 30, 2, 142

    CrossRef

  11. 11
    M. Morissette, M. Le Saux, M. D’Astous, S. Jourdain, S. Al Sweidi, N. Morin, E. Estrada-Camarena, Pablo Mendez, Luis Miguel Garcia-Segura, T. Di Paolo, Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain, The Journal of Steroid Biochemistry and Molecular Biology, 2008, 108, 3-5, 327

    CrossRef

  12. 12
    Marc Morissette, Sara Al Sweidi, Sophie Callier, Thérèse Di Paolo, Estrogen and SERM neuroprotection in animal models of Parkinson's disease, Molecular and Cellular Endocrinology, 2008, 290, 1-2, 60

    CrossRef

  13. 13
    Anete Curte Ferraz, Francesca Matheussi, Raphael Escorsim Szawka, Vanessa Rizelio, Ana Márcia Delattre, Paula Rigon, Érica do Espírito Santo Hermel, Léder Leal Xavier, Matilde Achaval, Janete A. Anselmo-Franci, Evaluation of Estrogen Neuroprotective Effect on Nigrostriatal Dopaminergic Neurons Following 6-Hydroxydopamine Injection into the Substantia Nigra Pars Compacta or the Medial Forebrain Bundle, Neurochemical Research, 2008, 33, 7, 1238

    CrossRef

  14. 14
    M.C. Morale, F. L'Episcopo, C. Tirolo, G. Giaquinta, S. Caniglia, N. Testa, P. Arcieri, P.-A. Serra, G. Lupo, M. Alberghina, N. Harada, S. Honda, G.C. Panzica, Bianca Marchetti, Loss of aromatase cytochrome P450 function as a risk factor for Parkinson's disease?, Brain Research Reviews, 2008, 57, 2, 431

    CrossRef

  15. 15
    Li-Xing Liu, Wen-Fang Chen, Jun-Xia Xie, Man-Sau Wong, Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease, Neuroscience Research, 2008, 60, 2, 156

    CrossRef

  16. 16
    Chandani Lewis, Dean E. Dluzen, Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice, Neuroscience Letters, 2008, 448, 1, 130

    CrossRef

  17. 17
    Anita N. DiMeo, Ruth I. Wood, Self-administration of estrogen and dihydrotestosterone in male hamsters, Hormones and Behavior, 2006, 49, 4, 519

    CrossRef

  18. 18
    Kamal Shemisa, Vidhya Kunnathur, Bin Liu, Ty J. Salvaterra, Dean E. Dluzen, Testosterone modulation of striatal dopamine output in orchidectomized mice, Synapse, 2006, 60, 5
  19. 19
    L.I. Anderson, R.E. Leipheimer, D.E. Dluzen, Effects of neonatal and prepubertal hormonal manipulations upon estrogen neuroprotection of the nigrostriatal dopaminergic system within female and male mice, Neuroscience, 2005, 130, 2, 369

    CrossRef

  20. 20
    S. Jourdain, M. Morissette, N. Morin, T. Di Paolo, Oestrogens Prevent Loss of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter (VMAT2) in Substantia Nigra of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mice, Journal of Neuroendocrinology, 2005, 17, 8
  21. 21
    Myreille D'Astous, Marc Morissette, Sophie Callier, Thérèse Di Paolo, Regulation of striatal preproenkephalin mRNA levels in MPTP-lesioned mice treated with estradiol, Journal of Neuroscience Research, 2005, 80, 1
  22. 22
    Bin Liu, Jun Xia Xie, Dewi Kenneth Rowlands, Yu Lin Gou, Ching Cheong Leung, Yiu Wa Chung, Hsiao Chang Chan, Neuroprotective Effects of Bak Foong Pill in 1-Methyl-4-phenyl-1,2,3,6-tetrahyrdropyridine (MPTP)-Induced Parkinson's Disease Model Mice, Biological & Pharmaceutical Bulletin, 2004, 27, 8, 1245

    CrossRef

  23. 23
    M Ramsden, T.M Shin, C.J Pike, Androgens modulate neuronal vulnerability to kainate lesion, Neuroscience, 2003, 122, 3, 573

    CrossRef

  24. 24
    R.E. Myers, L.I. Anderson, D.E. Dluzen, Estrogen, but not testosterone, attenuates methamphetamine-evoked dopamine output from superfused striatal tissue of female and male mice, Neuropharmacology, 2003, 44, 5, 624

    CrossRef

  25. 25
    Aristea S Galanopoulou, Solomon L Moshé, Role of sex hormones in the sexually dimorphic expression of KCC2 in rat substantia nigra, Experimental Neurology, 2003, 184, 2, 1003

    CrossRef